Substituted homo-isoflavonoids were synthesized in order to study their in vitro anti-picornavirus activity. The maximum non-toxic concentration of the compounds for susceptible cells (HeLa) was determined, and the ability of non-cytotoxic concentrations to interfere with plaque formation by human rhinovirus (HRV) 1B and 14 and poliovirus (PV) 2 was examined. All the tested compounds were weakly effective against PV-2, while they exhibited a variable degree of activity against HRV-1B and -14 infection. Serotype 1B was much more sensitive than 14 to the action of the compounds, and the presence of one or more chlorine atoms increased the antiviral effect in all homo-isoflavonoids tested, confirming the positive influence of this substituent on activity.
Al NakibT., BezjakV., MeeganM.J., & ChandyR. (1995) Synthesis and antifungal activity of some 3-benzylidenechroman-4-ones, 3-benzylidenethiochroman-4-ones and 2-benzylidene-1-tetralones. European Journal of Medicinal Chemistry25: 455-462.
2.
AmschlerG., FrahmA.W., HatzelmannA., KilianU., Müller-DobliesD., & Müller-DobliesU. (1996) Constituents of Veltheimia viridifolia; I. Homoisoflavanones of the bulbs. Planta Medica62: 534-539.
3.
AndrieuxJ., BartonD.H.R., & PatinH. (1977) Rhodium-catalyzed isomerization of some unsaturated organic substrates. Journal of the Chemical Society Perkin TransactionsI: 359-363.
4.
BatchelorJ.F., BauerD.J., HodsonH.F., SelwayJ.W.T., & YoungD.A.B. (1979) Flavans and pharmaceutical compositions containing them. European Patent Application No. 4579. Chemical Abstracts (1980) 92: 128727j.
5.
BauerD.J., SelwayJ.W.T., BatchelorJ.F., TisdaleM., CaldwellJ.C., & YoungD.A.B. (1981) 4′,6-Dichloroflavan (BW683C), a new anti-rhinovirus compound. Nature292: 369-370.
6.
BlaskòG., & CordellG. (1988) Biomimetic total synthesis of dracaenone derivatives. Heterocycles27: 445-452.
7.
BohlerP., & TammC. (1967) The homoisoflavanones, a new class of natural products. Isolation and structure of eucomin and eucomolo. Tetrahedron Letters36: 3479-3483.
8.
BuraliC., DesideriN., SteinM.L., ContiC., & OrsiN. (1987) Synthesis and anti-rhinovirus activity of halogen substituted isoflavenes and isoflavans. European Journal of Medicinal Chemistry22: 119-123.
9.
CanaliniG., DeganiI., FochiR., & SpuntaG. (1967) Cationi eteroaromatici. – Nota X. Idrolisi di alcuni derivati del perclorato di cromilio. Annali di Chimica57: 1045-1072.
10.
ChatterjeaJ.N., ShawS.C., & SinghJ.N. (1974) Synthesis of anhydrobrazilic acid. Isomerization of arylidenechroman-4-ones to homoisoflavones. Journal of the Indian Chemical Society51: 281-288.
11.
ChatterjeaJ.N., ShawS.C., LaiP.K., & SinghJ.N. (1979) Homoisoflavones. Part IV. Further synthetical experiments. Journal of the Indian Chemical Society56: 1006-1009.
12.
ContiC., OrsiN., & SteinM.L. (1988) Effect of isoflavans and isoflavenes on rhinovirus 1B and its replication in HeLa cells. Antiviral Research10: 117-127.
13.
ContiC., DesideriN., OrsiN., SestiliI., & SteinM.L. (1990a) Synthesis and anti-rhinovirus activity of cyano and amidino substituted flavanoids. European Journal of Medicinal Chemistry25: 725-730.
14.
ContiC., GenoveseD., SantoroR., SteinM.L., OrsiN., & FioreL. (1990b) Activities and mechanisms of action of halogen-substituted flavanoids against poliovirus type 2 infection in vitro. Antimicrobial Agents and Chemotherapy34: 460-466.
15.
ContiC., TomaoP., GenoveseD., DesideriN., SteinM.L., & OrsiN. (1992) Mechanisms of action of antirhinovirus flavanoid 4′,6-dicyanoflavan. Antimicrobial Agents and Chemotherapy36: 95-99.
16.
DarmanadenR., DhanutrirtoH., CastelJ., LoubatiereJ., & FlandreO. (1984) Nouveaux dérivés de la benzopyrannone-4, a activités analgésique, anti-inflammatoire et antiagrégante plaquettaire. Il Farmaco39: 876-887.
17.
Della LoggiaR., Del NegroP., TubaroA., BaroneG., & ParrilliM. (1989) Homoisoflavanones as anti-inflammatory principles of Muscari comosum. Planta Medica55: 587-588.
18.
De MeyerN., HaemersA., MishraL., PandeyH.K., PietersL.A.C., Vanden BergheD.A., & VlietinckA.J. (1991) 4′-hydroxy-3-methoxyflavones with potent antipicornavirus activity. Journal of Medicinal Chemistry34: 736-746.
19.
DesideriN., SestiliI., SteinM.L., ContiC., TomaoP., & OrsiN. (1995) Synthesis and anti-rhinovirus 1B activity of oxazolinylflavans. Antiviral Chemistry and Chemotherapy1: 307-312.
20.
DesideriN., ContiC., SestiliI., TomaoP., SteinM.L., & OrsiN. (1992) Synthesis and evaluation of anti-rhinovirus 1B activity of oxazolinyl-isoflavans and -3(2H)-isoflavenes. Antiviral Chemistry and Chemotherapy3: 195-202.
21.
DesideriN., ContiC., SestiliI., TomaoP., SteinM.L., & OrsiN. (1995) In vitro evaluation of the anti-picornavirus activities of new synthetic flavonoids. Antiviral Chemistry and Chemotherapy6: 298-306.
22.
FarkasL., GottsegenA., NogradiM., & StreliskyJ. (1971) Synthesis of homoisoflavanones – II. Constituents of Eucomis autumnalis and Eucomis punctata. Tetrahedron27: 5049-5054.
23.
FialaM., & KennyG.E. (1966) Enhancement of rhinovirus plaque formation in human heteroploid cell cultures by magnesium and calcium. Journal of Bacteriology92: 1710-1715.
24.
FujuiM., SuharaY., & IshitsukaH. (1980) Substituted acetophenones. European Patent Application No. 13960. Chemical Abstracts (1981) 94: 83777y.
25.
GenoveseD., ContiC., TomaoP., DesideriN., SteinM.L., CatoneS., & FioreL. (1995) Effect of chloro, cyano, and amidino-substituted flavanoids on enterovirus infection in vitro. Antiviral Research27: 123-136.
KirkiacharianS., & AloulouM. (1984) Homoisoflavonoids: new biomimetic type method for synthesis of 3-benzyl-4-chromanones and 3-benzyl-3-(hydroxymethyl)-4-chromanones. Comptes Rendus de l'Academie des Sciences Serie II299: 187-190.
28.
KirkiacharianS., TongoH.G., BastideJ., BastideP., & GrenieM.M. (1989) Synthèse et activités angioprotectrice, anti-allergique et antihistaminique de benzyl-3-chromones (homo-isoflavones)European Journal of Medicinal Chemistry24: 541-546.
29.
LévaiA., & SchagJ.B. (1979) Synthesis of 3-benzylidenechroman-4-ones and -1-thiochroman-4-ones. Pharmazie34: 749.
30.
LévaiA., & SzabòZ., (1992) Synthesis of exocyclic a, b-unsaturated ketones. Pharmazie47: 56-57.
31.
LévaiA., DinyaZ., SchagJ.B., & SzollosyA. (1981) Synthesis of 3-benzyl-4-chromones and 3-benzyl-1-thio-4-chromones. Pharmazie36: 465-466.
32.
Lonberg-HolmK., & ButterworthB.E. (1976) Investigation of the structure of polio-rhinovirions through the use of selective chemical reactivity. Virology71: 207-216.
33.
LoudonJ.D., & RazdanR.K. (1954) Rearrangements of chromanones and dihydrocoumarins by aluminium chloride. Journal of the Chemical Society:4299-4303.
34.
MerchantJ.R., & UpasaniR.B. (1980) A simplified synthesis of chromanones. Current Science49: 587-589.
35.
MulvaghD., MeeganM.J., & DonnellyD. (1979) Rearrangment of 3-benzylidenechroman-4-ones. Journal of Chemical Research (Synopses): 137.
36.
NamikoshiM., NakataH., YamadaH., NagaiM., & SaitohT. (1987) Homoisoflavonoids and related compounds. II. Isolation and absolute configurations of 3,4-dihydroxylated homoisoflavans and brazilins from Caesalpinia sappan L. Chemical and Pharmaceutical Bulletin35: 2761-2773.
37.
NewmanJ.F.E., RowlandsD.J., & BrownF. (1973) A physico-chemical sub-grouping of the mammalian picornaviruses. Journal of General Virology18: 171-180.
38.
PfeifferP., GrimmK., & SchmidtH. (1949) Zur Kenntnis der Chromene und Chromane. Annalem der Chemie564: 208-219.
39.
QuagliaM.G., DesideriN., BossùE., MelchiorreP., & ContiC. (1991) Enantiomeric separation by HPLC/DAD of substituted flavanoids. Journal of Pharmaceutical and Biomedical Analysis9: 811-815.
40.
QuagliaM.G., DesideriN., BossùE., SestiliI., & ContiC. (1992) 4′,6-Dichloroflavan (BW863C): enantiomeric separation by HPLC/DAD and antirhinovirus activity. Chirality4: 65-67.
41.
QuagliaM.G., DesideriN., BossùE., SestiliI., TomaoP., ContiC., & OrsiN. (1993) Chiral discrimination and antipicornavirus activity of 6-oxazolinylisoflavan. Chirality5: 356-358.
42.
RaviséA., & KirkiacharianB.S. (1978) Influence de la structure de composès phénoliques sur l'inhibition du Phytophthora parasitica et d'enzymes participant aux processus parasitaires. III. Homoisoflavanones. Phythopathologische Zeitschrift92: 36-50.
43.
SupertiF., SegantiL., OrsiN., DiviziaM., GabrieliR., PanàA., & SteinM.L. (1989) Effect of isoflavans and isoflavenes on the infection of Frp/3 cells by hepatitis A virus. Antiviral Research11: 247-254.
44.
WallM.E., WaniM.C., ManikumarH.T., TaylorH., & McGivneyR. (1989) Plant antimutagens, 6. Intricatin and intricatinol, new antimutagenic homoisoflavonoids from Hoffmanosseggia Intricata. Journal of Natural Products52: 774-778
